Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
AssigneePrecisionBiotics Group Limited
InventorsBarry Kiely, Liam O'Mahony, David Groeger
Life of this patent
Estimating the term…
Abstract
Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.
Claims5
A method for the treatment of a respiratory viral infection in a subject, the method comprising administering to the subject in need thereof an effective amount of a strain of Bifidobacterium longum having the accession number NCIMB 42020.
Dependencies are inferred from the claim text.